| 000 | 01392 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516085215.0 | ||
| 264 | 0 | _c20121210 | |
| 008 | 201212s 0 0 eng d | ||
| 022 | _a1873-7560 | ||
| 024 | 7 |
_a10.1016/j.eururo.2012.03.048 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aProcopio, Giuseppe | |
| 245 | 0 | 0 |
_aRe: Camillo Porta, Emiliano Calvo, Miguel A. Climent, et al. Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial. Eur Urol 2012;61:826-33. _h[electronic resource] |
| 260 |
_bEuropean urology _cJul 2012 |
||
| 300 |
_ae5-6; author reply e7-8 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aSirolimus _xanalogs & derivatives |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 700 | 1 | _aVerzoni, Elena | |
| 700 | 1 | _aDe Braud, Filippo | |
| 773 | 0 |
_tEuropean urology _gvol. 62 _gno. 1 _gp. e5-6; author reply e7-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eururo.2012.03.048 _zAvailable from publisher's website |
| 999 |
_c21688979 _d21688979 |
||